Becton Dickinson (BDX) FCF Margin (2009 - 2026)
Becton Dickinson's (BDX) quarterly FCF Margin came in at 12.7% in Q2 2026, down 687.0% year-over-year from 2.16% in Q2 2025, and up 9.68% quarter-over-quarter from 11.58% in Q1 2026.
Powered by 
Analysis
Becton Dickinson (BDX) FCF Margin (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported FCF Margin for 18 consecutive years, with 12.7% the latest figure, recorded in Q2 2026.
- On a quarterly basis, FCF Margin fell 687.0% year-over-year to 12.7% in Q2 2026; TTM through Jun 2026 was 13.78%, a 329.0% increase from a year earlier, with the FY2025 full-year figure at 12.23%, down 323.0% from the prior year.
- FCF Margin was 12.7% for Q2 2026 at Becton Dickinson, up from 11.58% in the prior quarter.
- Over five years, FCF Margin peaked at 22.4% in Q2 2024 and troughed at 7.1% in Q1 2025.
- A 5-year average of 11.41% and a median of 12.14% in 2026 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin plunged 1762 bps in 2022 and surged 1868 bps in 2026, its largest moves.
- Over 5 years, FCF Margin stood at 4.16% in 2022, then soared by 277 bps to 15.7% in 2023, then fell by 28 bps to 11.38% in 2024, then retreated by 8 bps to 10.45% in 2025, then gained by 22 bps to 12.7% in 2026.
- The last three FCF Margin figures came in at 12.7% (Q2 2026), 11.58% (Q1 2026), and 10.45% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.48 Bn | 48.62 Bn | 2.32 Bn | 12.70% |
| 2 | Medline | 29.24 Bn | 26.56 Bn | 2.22 Bn | 7.86% |
| 3 | West Pharmaceutical Services | 23.94 Bn | 23.51 Bn | 329.20 Mn | 9.26% |
| 4 | Baxter International | 12.66 Bn | 10.51 Bn | 1.03 Bn | 6.11% |
| 5 | Stevanato Group S.p.A | 5.51 Bn | 5.40 Bn | 100.91 Mn | 29.65% |
| 6 | Acme United | 233.67 Mn | 228.63 Mn | 26.69 Mn | 19.22% |
| 7 | Rockwell Medical | 31.87 Mn | 7.07 Mn | 3.24 Mn | 8.41% |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | -24.47% |
| 9 | United Health Products | 9.09 Mn | 9.06 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 7.45 Mn | 4.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.70% |
| Mar 31, 2026 | 11.58% |
| Dec 31, 2025 | 10.45% |
| Sep 30, 2025 | 17.77% |
| Jun 30, 2025 | 19.57% |
| Mar 31, 2025 | -7.10% |
| Dec 31, 2024 | 11.38% |
| Sep 30, 2024 | 16.22% |
| Jun 30, 2024 | 22.40% |
| Mar 31, 2024 | 7.53% |
| Dec 31, 2023 | 15.70% |
| Sep 30, 2023 | 20.27% |
| Jun 30, 2023 | 18.25% |
| Mar 31, 2023 | 0.08% |
| Dec 31, 2022 | 4.16% |
| Sep 30, 2022 | 13.82% |
| Jun 30, 2022 | 9.16% |
| Mar 31, 2022 | 1.43% |
| Dec 31, 2021 | 7.35% |
| Sep 30, 2021 | 8.02% |